BioAge Labs (BIOA) Preferred Stock Liabilities (2023 - 2024)

BioAge Labs (BIOA) has 2 years of Preferred Stock Liabilities data on file, last reported at $342.8 million in Q2 2024.

• For the quarter ending Q2 2024, Preferred Stock Liabilities changed N/A year-over-year to $342.8 million; the trailing twelve-month figure through Jun 2024 stood at $342.8 million (changed N/A YoY), and the FY2023 full-year result was $18.2 million, changed N/A from the prior year.
• Preferred Stock Liabilities was little changed at $342.8 million in Q2 2024, from $342.8 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $342.8 million in Q1 2024 to a low of $18.2 million in Q4 2023.